Target intelligence / Profile preview

Hemostasis via multi-herbal synergistic action

Molecular classification
Other
01

Overview

The term "Hemostasis via multi-herbal synergistic action" does not refer to a single molecule, receptor, enzyme, or canonical therapeutic target. Instead, it describes a therapeutic strategy where combinations of herbal medicines are used to influence the process of blood clotting through multiple mechanisms. These mechanisms may include inhibition or promotion of platelet aggregation, modulation of coagulation factors such as thrombin or factor Xa, anti-inflammatory actions that affect vascular integrity and repair processes, and antioxidant effects that protect tissues during injury[1][2]. Research into multi-herb synergy has shown that certain combinations—such as those containing Ginkgo biloba—can have additive or synergistic effects on targets like platelet function and inflammatory mediators. However, these actions result from the combined activity of many bioactive compounds acting on diverse molecular pathways rather than interaction with a single defined biological target[1][2]. Because this is not a discrete molecule or protein but rather an approach involving complex mixtures acting on multiple systems simultaneously—and because there is no standardized nomenclature nor recognized abbreviation—it cannot be classified under standard molecular families like "receptor," "enzyme," etc., nor can it be mapped to existing drug-target databases. In summary: This entry is not a valid therapeutic target according to standard biomedical definitions; it represents an area of research focused on the polypharmacology and potential clinical benefits/challenges associated with using complex herbal formulations for modulating hemostasis.

Other names
Multi-herbal synergistic action in hemostasisHerbal synergy for coagulationSynergistic herbal hemostatic effect
02

Biological functions

HemostasisBlood coagulationAnti-apoptosis (context-dependent)Anti-inflammatory response (context-dependent)Neuroprotection (context-dependent)
03

Disease associations

Hemorrhage/bleeding disorders (potential application)Stroke (in context of neuroprotection and vascular effects)Cancer (in context of adjunctive therapy, not direct hemostasis)
04

Safety considerations

Herb–drug interactions with anticoagulants/antiplateletsVariability in composition and potency between preparationsPotential for unpredictable pharmacokinetics/pharmacodynamics

Beyond the preview

Go deeper on Hemostasis via multi-herbal synergistic action.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemostasis via multi-herbal synergistic action.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call